VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2021

May 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2021-05-01

Reporting Person: MCGLYNN MARGARET G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-01	Common Stock	A	921	$0.00	Acquired	1798	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-01	Stock Option (Right to Buy)	$217.20	A	3034	Acquired	2031-04-30	Common Stock (3034)	Direct

Footnotes

F1: Restricted stock unit award that vests on the first anniversary of the grant date.

F2: Fully vested.